论文部分内容阅读
最近,卫生部和国家医药管理局关于修改氨酚待因片管理办法的通知指出:氨酚待因片新药自卫生部1986年5月30日以(86)×—01号函批准试产以来,经卫生部指定北京医科大学临床药理研究所牵头,安排十家医院进行第三期临床研究工作完成后,召集卫生部药品评审委员和有关专家进行了评审,认为该药镇痛疗效优良,副作用轻微,经对700多例病人用药后的依赖性观察,未发现有成瘾病例和在人群中的滥用倾向。卫生部根据专家的建议,同
Recently, the Ministry of Health and the State Pharmaceutical Administration have announced on the revision of the management measures for paracetamol to be treated as a result that the drug for paracetamol has been approved for trial production by the Ministry of Health since May 30, 1986 (86) × -01 , The Ministry of Health designated Beijing Medical University Institute of Clinical Pharmacology to take the lead to arrange ten hospitals for the third phase of clinical research work is completed after the convening of the Ministry of Health Pharmaceutical Evaluation Committee and the experts reviewed the drug that the drug analgesic efficacy of the side effects Slightly, after more than 700 cases of patients dependence on the observation, did not find addicted cases and abuse in the population tend to. Ministry of Health, according to expert advice, with